People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Please provide your email address to receive an email when new articles are posted on . Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma.

MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic ...

Findings showed that in patients treated with glecaprevir/pibrentasvir, the overall SVR12 rate was 96%, with 0 patients experiencing virologic failure. The Food and ...

In the wake of recent breakthroughs in the management of hepatitis C virus (HCV) infection, with several new promising medications available on the market and more being studied in clinical trials, it ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost ...

Maternal hepatitis C virus (HCV) infection is associated with a twofold increase in NICU admissions and nearly threefold increase in small-for-gestational-age births below the 5th percentile.

The hepatitis C virus—HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens of millions of people worldwide and there is no ...

ASL Napoli 1 Centro promotes a campaign to inform citizens about the possibility of free screening to eliminate the Hepatitis ...

Hepatitis C is incredibly common in the U.S., but many people don't look sick at first—or even know they have it. It's not as frequently discussed as Hepatitis A and B, which we have vaccines for, but ...